Cargando…
Central Application of Aliskiren, a Renin Inhibitor, Improves Outcome After Experimental Stroke Independent of Its Blood Pressure Lowering Effect
Epidemiological studies suggest that pharmacological reduction of systemic hypertension lowers incidence and severity of stroke. However, whether the reduction of blood pressure per se or the compounds used to reduce hypertension are responsible for this effect received little attention. In the curr...
Autores principales: | Panahpour, Hamdollah, Terpolilli, Nicole A., Schaffert, David, Culmsee, Carsten, Plesnila, Nikolaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737892/ https://www.ncbi.nlm.nih.gov/pubmed/31551909 http://dx.doi.org/10.3389/fneur.2019.00942 |
Ejemplares similares
-
Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy
por: Sureshkumar, Kalathil K
Publicado: (2008) -
Aliskiren: An orally active renin inhibitor
por: Wal, Pranay, et al.
Publicado: (2011) -
Direct Renin Inhibition: Focus on Aliskiren
por: Pool, James L.
Publicado: (2007) -
Effects of Aliskiren on Stroke in Rats Expressing Human Renin and Angiotensinogen Genes
por: Schmerbach, Kristin, et al.
Publicado: (2010) -
RIPK1 or RIPK3 deletion prevents progressive neuronal cell death and improves memory function after traumatic brain injury
por: Wehn, Antonia Clarissa, et al.
Publicado: (2021)